Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam Added to Russell 3000 Index

NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals was added to the Russell 3000 and Russell 2000 after the markets closed on June 30, the company said today.
 
Alynlam said its inclusion in these indexes reflects an interest "in the potential of RNAi for therapeutic applications, and the promise of this technology," said John Maraganore, president and CEO of Alnylam Pharmaceuticals.
 
The Russell Indeces include only common stocks belonging to US corporations. The Russell 3000 measures the performance based on total market capitalization. Alnylam's market cap is currently $471 million.
 
Also listed on this index are: Applied Biosystems, Affymetrix, Agilent, Beckman Coulter, Becton Dickinson, Bio-Rad, Bruker BioSciences, Cepheid, DeCode, Fisher Scientific, General Electric, Illumina, Invitrogen, Luminex, Molecular Devices, PerkinElmer, Serologicals, Sigma-Aldrich, Solexa (which was added earlier this week), Thermo Electron, and Waters.
 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.